2022
DOI: 10.1007/s13402-022-00687-4
|View full text |Cite
|
Sign up to set email alerts
|

Therapeutic exosomes loaded with SERPINA5 attenuated endometrial cancer cell migration via the integrin β1/FAK signaling pathway

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
2
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
(4 citation statements)
references
References 32 publications
0
2
0
Order By: Relevance
“…When SERPINA5 or serpin proteins are overexpressed using lentivirus in HEK293 cells, the resulting EVs display efficacy by influencing the intended pathways as designed by the researchers (Fig. 3 C) [ 57 , 58 ]. Similarly, there are studies that the Tat protein and low-density lipoprotein receptor (Ldlr) protein were transfected into HEK293T cells using lipofectamine instead of lentivirus to functionalize EVs.…”
Section: Engineering Methods Of Ev and Applications For Regenerative ...mentioning
confidence: 99%
See 1 more Smart Citation
“…When SERPINA5 or serpin proteins are overexpressed using lentivirus in HEK293 cells, the resulting EVs display efficacy by influencing the intended pathways as designed by the researchers (Fig. 3 C) [ 57 , 58 ]. Similarly, there are studies that the Tat protein and low-density lipoprotein receptor (Ldlr) protein were transfected into HEK293T cells using lipofectamine instead of lentivirus to functionalize EVs.…”
Section: Engineering Methods Of Ev and Applications For Regenerative ...mentioning
confidence: 99%
“… Engineered materials Method Targeting cell Ref. 1 PDGFR-RVG, hnRNPA2B1expressed/mirSilencer lentivirus HEK293T [ 51 ] 2 RVG/BDNF lentivirus HEK293T [ 52 ] 3 SERPINA5 protein lentivirus HEK293 [ 57 ] 4 Serpin protein lentivirus HEK293 [ 58 ] 5 miR-146a lentivirus PMSC [ 56 ] 6 miR-214-3p lentivirus UCMSC [ 55 ] 7 miR-133-3p lentivirus UCMSC [ 54 ] 8 Tat protein Lipofectamine HEK293T [ 59 ] 9 Ldlr mRNA Lipofectamine HEK293T [ 60 ] 10 Protein drug (srIkB) Effectene Transfection Reagent HEK293T [ 61 ] 11 Protein drug (srIkB) Effectene Transfection Reagent HEK293T [ 62 ] 12 Protein drug (srIkB) Effectene Transfection Reagent HEK293T [ 63 ]
Fig. 3 Gene editing approaches for EV engineering.
…”
Section: Engineering Methods Of Ev and Applications For Regenerative ...mentioning
confidence: 99%
“…Song et al detected Serpin family A member 5 (SERPINA5) protein levels in plasma EVs. It was found that circulating plasma levels of the extracellular vesicles of SERPINA5 were elevated in EC patients, SERPINA5 expression was reduced in EC patients with distant metastases, and low SERPINA5 expression indicated poor survival [ 82 ]. Zhou et al compared plasma from healthy subjects and EC patients and found that the extracellular vesicles of miR-15a-5p, miR-106b-5p, and miR107 were significantly upregulated in the plasma of EC patients compared to healthy subjects.…”
Section: Progress In the Treatment Of Evs In Ecmentioning
confidence: 99%
“…In addition, the extracellular vesicular SERPINA5 protein hindered tumor growth and metastasis in xenograft models. Thus, the SERPINA5 EVs may be a new strategy for treating metastatic EC [ 82 ]. Wang et al found that upregulation of miR-192-5p by TAMs-derived EVs inhibited the IRAK1/NF-kB signaling pathway, effectively promoting apoptosis and impeding EMT in EC cells, thereby inhibiting EC progression.…”
Section: Progress In the Treatment Of Evs In Ecmentioning
confidence: 99%